A novel ATP-competitive pan-specific Akt kinase inhibitor. (IC50s=2, 13, 9 nM for Akt1, 2 and 3 respectively)(1). Antitumor activity. Active in vivo. Induces hyperglycemia (2). Cell permeable.
Productname
GSK-690693 HCl
A16-900-25
Are you looking for specific products, alternatives or documentation?